TGFβ1 is reported to upregulate the stem-like properties of HSC [14] and LIC [15], and AML cells with intermediate ALDH activity are reported to be highly represented in minimal residual disease AML samples [16]. The gene discussed is TGFB1; the disease is acute myeloid leukemia.